Differences in Atrial Remodeling in Hypertrophic Cardiomyopathy Compared to Hypertensive Heart Disease and Athletes'

Helge Servatius1, Simon Raab1, Babken Asatryan1

  • 1Department of Cardiology, Inselspital, Bern University Hospital, University of Bern, 3010 Bern, Switzerland.

Insights

Atrial remodeling is more advanced in hypertrophic cardiomyopathy (HCM) patients than in hypertensive heart disease (HHD) patients and athletes, as shown by ECG and echocardiographic data. This finding may help differentiate these conditions, which share a higher prevalence of atrial fibrillation.

Area of Science:

  • Cardiology
  • Electrophysiology
  • Cardiac Imaging

Background:

  • Hypertrophic cardiomyopathy (HCM), hypertensive heart disease (HHD), and athlete's heart share an increased prevalence of atrial fibrillation.
  • Atrial cardiomyopathy characteristics may differ across these conditions, potentially aiding in their differentiation.

Purpose of the Study:

  • To compare atrial remodeling characteristics in patients with HCM, HHD, and endurance athletes.
  • To identify potential electrocardiographic and echocardiographic markers for distinguishing between HCM, HHD, and athlete's heart.

Main Methods:

  • Prospective, single-center study analyzing 12-lead ECG, signal-averaged ECG (SAECG), 24-hour Holter ECG, and echocardiographic data.
  • Exclusion of patients with atrial fibrillation.
  • Comparison of data from 27 HCM patients, 324 HHD patients, and 215 endurance athletes.

Main Results:

  • HCM patients exhibited significantly longer filtered P-wave duration and PR interval compared to HHD patients and athletes.
  • Left atrial volume index (LAVI) was significantly larger in HCM patients (43 ± 14 mL/m²) compared to HHD (30 ± 10 mL/m²) and athletes (31 ± 9.5 mL/m²).
  • Premature atrial complexes per hour were more frequent in HHD patients (27 ± 86) than in HCM (4.9 ± 16) and athletes (2.7 ± 23).

Conclusions:

  • Structural and electrical atrial remodeling is more advanced in HCM patients compared to HHD patients and endurance athletes.
  • Distinct atrial remodeling patterns may serve as differentiating factors for HCM, HHD, and athlete's heart.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
78
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
82
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
52
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
96
Structure of Cardiac Muscles01:13

Structure of Cardiac Muscles

Cardiac muscle, or myocardium, is a specialized type of muscle found exclusively in the heart. Its unique structural and functional characteristics enable the heart to perform its vital role of pumping blood throughout the body continuously and rhythmically. The cardiac muscle cells, or cardiomyocytes, possess an endomysium and perimysium but do not have an epimysium.
Compared to skeletal muscles, cardiac muscle cells are small and mostly have a single nucleus. Additionally, they are usually...
14.5K
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
71